BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kasht R, Borogovac A, George JN. Frequency and severity of pregnancy complications in women with hereditary thrombotic thrombocytopenic purpura. Am J Hematol 2020;95:E316-8. [PMID: 32808675 DOI: 10.1002/ajh.25964] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
Number Citing Articles
1 Dahlan R, Bablghaith E. Hereditary thrombotic thrombocytopenic purpura (TTP) with co-occurring autosomal dominant polycystic kidney disease (ADPKD). BMJ Case Rep 2022;15:e250378. [DOI: 10.1136/bcr-2022-250378] [Reference Citation Analysis]
2 He Y, Yang H. Clinical diagnosis and treatment of “atypical” HELLP syndrome. Gynecology and Obstetrics Clinical Medicine 2022;2:105-108. [DOI: 10.1016/j.gocm.2022.08.001] [Reference Citation Analysis]
3 Brown J, Potugari B, Mazepa MA, Kohli R, Moliterno AR, Brodsky RA, Vaught JA, Burwick R, Chaturvedi S. Maternal and fetal outcomes of pregnancy occurring after a diagnosis of immune-mediated thrombotic thrombocytopenic purpura. Ann Hematol 2022. [PMID: 35932324 DOI: 10.1007/s00277-022-04936-2] [Reference Citation Analysis]
4 George JN. Thrombotic Thrombocytopenic Purpura: From 1972 to 2022 and Beyond. Semin Thromb Hemost 2022. [PMID: 35793688 DOI: 10.1055/s-0042-1749589] [Reference Citation Analysis]
5 Galstyan GM, Shmakov RG, Klebanova ЕЕ, Troitskaya VV, Dvirnyk VN, Surin VL, Pshenichnikova OS, Pozdnyakova YM, Polushkina ES, Gaponova TV, Mamleeva SY, Pyregov AV, Rogachevskiy ОV, Sysoeva EP, Tsvetaeva NV. Thrombotic thrombocytopenic purpura in pregnancy. Giving birth or not giving birth, that is the question. Gematologiâ i transfuziologiâ 2022;67:42-61. [DOI: 10.35754/0234-5730-2022-67-1-42-61] [Reference Citation Analysis]
6 Perez Botero J, Reese JA, George JN, McIntosh JJ. Severe thrombocytopenia and microangiopathic hemolytic anemia in pregnancy: A guide for the consulting hematologist. Am J Hematol 2021;96:1655-65. [PMID: 34424560 DOI: 10.1002/ajh.26328] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
7 Sant'Antonio E, Borsani O, Camerini C, Botta C, Santoro M, Allegra A, Siragusa S. Philadelphia chromosome-negative myeloproliferative neoplasms in younger adults: A critical discussion of unmet medical needs, with a focus on pregnancy. Blood Rev 2021;:100903. [PMID: 34742614 DOI: 10.1016/j.blre.2021.100903] [Reference Citation Analysis]
8 Galstyan GM, Maschan AA, Klebanova EE, Kalinina II. Treatment of thrombotic thrombocytopenic purpura. Terapevticheskii arkhiv 2021;93:826-829. [DOI: 10.26442/00403660.2021.07.200914] [Reference Citation Analysis]
9 Siddiqui A, Journeycake JM, Borogovac A, George JN. Recognizing and managing hereditary and acquired thrombotic thrombocytopenic purpura in infants and children. Pediatr Blood Cancer 2021;68:e28949. [PMID: 33660913 DOI: 10.1002/pbc.28949] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]